WEKO3
アイテム
Lovastatin inhibits visceral allodynia and increased colonic permeability induced by lipopolysaccharide or repeated water avoidance stress in rats.
https://asahikawa-med.repo.nii.ac.jp/records/6050
https://asahikawa-med.repo.nii.ac.jp/records/605039e2b3e2-86b4-42a5-a572-5aac1ec59f5f
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
6927.pdf (1.4 MB)
|
|
| Item type | 学術雑誌論文 / Journal Article_02(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2018-01-16 | |||||
| タイトル | ||||||
| タイトル | Lovastatin inhibits visceral allodynia and increased colonic permeability induced by lipopolysaccharide or repeated water avoidance stress in rats. | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | Gut permeability | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | Irritable bowel syndrome | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | Lipopolysaccharide | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | Lovastatin | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | Visceral pain | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | Water avoidance stress | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | journal article | |||||
| 著者 |
野津, 司
× 野津, 司× 宮岸, 沙織× 粂井, 志麻× 野津, 麟太郎× 高草木, 薫× 奥村, 利勝 |
|||||
| 著者 ローマ字 | ||||||
| 値 | Nozu, Tsukasa | |||||
| 著者 ローマ字 | ||||||
| 値 | Miyagishi, Saori | |||||
| 著者 ローマ字 | ||||||
| 値 | Kumei, Shima | |||||
| 著者 ローマ字 | ||||||
| 値 | Nozu, Rintaro | |||||
| 著者 ローマ字 | ||||||
| 値 | Takakusaki, Kaoru | |||||
| 著者 ローマ字 | ||||||
| 値 | Okumura, Toshikatsu | |||||
| 書誌情報 |
European Journal of Pharmacology 巻 818, p. 228-234, 発行日 2018-01-01 |
|||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 0014-2999 | |||||
| DOI | ||||||
| 関連タイプ | isVersionOf | |||||
| 識別子タイプ | DOI | |||||
| 関連識別子 | 10.1016/j.ejphar.2017.10.056 | |||||
| 識別番号 その他 | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | PMID：29107672 | |||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Statins have been reported to block inflammatory somatic pain and have an anti-cytokine property. Lipopolysaccharide (LPS) or repeated water avoidance stress (WAS) induces visceral hypersensitivity and increases gut permeability in rats, which are mediated through proinflammatory cytokine-dependent pathways. Since visceral hypersensitivity with increased gut permeability plays a crucial role in the pathophysiology of irritable bowel syndrome (IBS), these above animal models are considered to simulate IBS. We hypothesized that lovastatin improves symptoms in the patients with IBS by attenuating these visceral changes. The threshold of visceromotor response (VMR) induced by colonic balloon distention was measured for the assessment of visceral sensation in rats. Colonic permeability was determined in vivo by quantifying the absorbed Evans blue in colonic tissue for 15min using a spectrophotometer. Subcutaneously (s.c.) injected LPS (1mg/kg) reduced the threshold of VMR after 3h. Pretreatment with lovastatin (20mg/kg s.c. daily for 3 days) abolished this response by LPS. Repeated WAS (1h daily for 3 days) induced visceral allodynia, which was also blocked by repeated injection of lovastatin before each stress session. The antinociceptive effect of lovastatin on the LPS-induced allodynia was reversed by mevalonolactone, NG-nitro-L-arginine methyl ester or naloxone. Lovastatin also blocked the LPS- or repeated WAS-induced increased gut permeability. These results indicate the possibility that lovastatin can be useful for treating IBS. | |||||
| 注記 | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | CC-BY-NC-ND | |||||
| 資源タイプ | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | text | |||||
| 著者版フラグ | ||||||
| 出版タイプ | AM | |||||
| 出版タイプResource | http://purl.org/coar/version/c_ab4af688f83e57aa | |||||
| フォーマット | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | application/pdf | |||||
| ID(XooNIps) | ||||||
| 値 | 29107672 | |||||
| 閲覧数(XooNIps) | ||||||
| 値 | 358 | |||||
| ダウンロード数(XooNIps) | ||||||
| 値 | 495 | |||||
